06, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA ... A replay of the webcasts will be ...
News Medical on MSN53 分钟
SAB BIO announces positive topline Phase 1 clinical results with potentially disease ...SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈